First Mercantile Trust’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$80K	Sell	4,433 -279	-6%	-$5.04K	0.01%	714
2021 Q2	$83K	Buy	+4,712	New	+$83K	0.01%	730
2017 Q2	–	Sell	-5,945	Closed	-$177K	–	811
2017 Q1	$177K	Buy	5,945 +600	+11%	+$17.9K	0.03%	604
2016 Q4	$145K	Buy	+5,345	New	+$145K	0.02%	663